Editas Medicine, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.38
|
|
Average Rating
|
3.32
|
|
# Strong Buys
|
5
|
|
# Buys
|
0
|
|
# Holds
|
11
|
|
# Sells
|
2
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.86
|
-0.81
|
0.05
|
5.81%
|
|
2022-06-30
|
-0.82
|
-0.78
|
0.04
|
4.88%
|
|
2022-03-31
|
-0.79
|
-0.74
|
0.05
|
6.33%
|
|
2021-12-31
|
-0.72
|
-0.61
|
0.11
|
15.28%
|
|
2021-09-30
|
-0.82
|
-0.57
|
0.25
|
30.49%
|
|
2021-06-30
|
-0.83
|
-0.81
|
0.02
|
2.41%
|
|
2021-03-31
|
-0.73
|
-0.86
|
-0.13
|
-17.81%
|
|
2020-12-31
|
-0.74
|
-1.00
|
-0.26
|
-35.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.33
|
|
2021-12-31
|
-2.85
|
|
2020-12-31
|
-2.00
|
|
2019-12-31
|
-2.69
|
|
2018-12-31
|
-2.33
|
|
2017-12-31
|
-2.98
|
|
2016-12-31
|
-3.03
|
|
2015-12-31
|
-4.05
|